[Anaphylaxis--life-threatening allergic reactions].
Pfaar
Oliver
O
Zentrum für Allergologie und Rhinologie der HNO-Universitäts-klinik Mannheim. oliver.pfaar@hno-wiesbaden.de
Klimek
Ludger
L
D000322:Adrenergic Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D000485:Allergens; D000707:Anaphylaxis / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000401:mortality; D002648:Child; D004630:Emergencies; D004837:Epinephrine / Q000008:administration & dosage / Q000627:therapeutic use; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006633:Histamine Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D017410:Practice Guidelines as Topic; D012189:Retrospective Studies; D013806:Theophylline / Q000008:administration & dosage / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000322:Adrenergic Agonists; D000485:Allergens; D005938:Glucocorticoids; D006633:Histamine Antagonists; D014665:Vasodilator Agents; D013806:Theophylline; D004837:Epinephrine